Signaling and targeting cellular pathways in leukaemia metabolism

Use of mesenchymal stromal cells against graft-versus-host disease

Next generation sequencing and the monoclonal structure of multiple myeloma

Mouse models and proteomics tackling acute lymphoblastic leukaemia

New drugs for relapsed and refractory Hodgkin's lymphoma

Phase 1-2 results for oral proteasome inhibitor MLN9708 for multiple myeloma (Spanish)

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

MEK inhibitor, trametinib, improves progression free survival in melanoma

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma

Drug development in small cell and non-small cell lung cancer

ASCO 2012 Drug Development Research Professorship

Early phase trial of ibrutinib for chronic lymphocytic leukaemia